Adding TAR-200 to neoadjuvant cetrelimab improved the pCR rate in patients with muscle-invasive bladder cancer in a phase 2 trial.

Aldosterone increases blood pressure and contributes to chronic kidney disease (CKD) progression. Trial findings suggest baxdrostat may be an effective treatment.

Anrikefon is a kappa opioid receptor agonist with enhanced affinity for the receptor and minimal penetration of the blood-brain barrier.

Each additional Geriatric Oncology-PIM linked to 66 percent increase in odds of being mildly, moderate-to-severely frail at diagnosis.

Intervention resulted in a 17 percent absolute improvement in closing BP gaps, increased MA Star performance.

The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online Sept. 3 in JAMA Network Open. Diya Surie ...

Greater risk for CVD mortality seen in association with elevated blood pressure and hypertension at age 7 years.

The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.

(HealthDay News) — Poor cardiovascular-kidney-metabolic (CKM) health is associated with an increased risk for psoriasis, especially for those with high genetic risk, according to a study published ...

An investigational factor XI inhibitor shows early promise for treating atrial fibrillation in patients with a degree of kidney impairment.

Multiparametric MRI was a game changer for prostate cancer diagnosis. Now trial findings suggest a simpler imaging protocol may be as effective.

However, BCC rates similar by College of American Pathologists and Clinical and Laboratory Standards Institute criteria.